EUVIMEDEUVIMED entdecken
Open Access

Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition

Gregory Oxenkrug iD, Stefano Comai iD

International Journal of Tryptophan Research · 2026-08 · 19

DOI: 10.1177/11786469261472317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Tryptophan Research, online erschienen am 06.08.2026. Verfasst von Gregory Oxenkrug und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tufts University School of Medicine, Boston, MA, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of indoleamine 2,3-dioxygenase (IDO) is a promising therapeutic strategy for cognitive impairment in Alzheimer’s disease (AD). The pro-cognitive effect is often attributed to restoring glycolysis by preventing tryptophan (Trp) conversion to kynurenine (Kyn). However, this overlooks the metabolic fate of Trp when IDO is blocked. Since IDO and tryptophan 2,3-dioxygenase (TDO) compete for the same substrate, inhibiting IDO may shunt Trp toward TDO, potentially increasing Kyn and its downstream catabolites. This commentary explores the hypothesis that the upregulation of anthranilic acid (AA), a Kyn catabolite, contributes to the cognitive benefits of IDO inhibition. Recent evidence shows elevated AA in animal models of AD and individuals with mild cognitive impairment and preclinical AD, where it may serve as an early biomarker. Notably, these elevations and the pro-cognitive effects of AA-modulating compounds like sodium benzoate exhibit sex-specificity, being more prominent in females. The mechanism may involve AA’s dual action on G-protein coupled receptors: antagonism of GPR17 promotes myelination, while agonism of GPR109A may protect myelin from degradation. Preserving myelin integrity is critical, as demyelination is an early event in AD pathogenesis. We propose that AA upregulation is not merely a biomarker but part of a compensatory defense mechanism. Therefore, the pro-cognitive effect of IDO inhibition may be partly mediated by the subsequent shunting of Trp toward TDO and production of the myelin-preserving metabolite, AA. This reframes the therapeutic goal from reducing neurotoxic kynurenines to leveraging the protective potential of the entire pathway.

Schlagwörter

Stichwörter der Autor:innen

GPR109AGPR17anthranilic acidcognitive impairmentdisease/health conditionindoleamine 2,3-dioxygenasekynureninemyelintryptophantryptophan 2,3-dioxygenase

Autor:innen und Institutionen

  • Tufts University School of Medicine, Boston, MA, USA.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Italy.
  • Department of Psychiatry, McGill University, Montreal, QC, Canada.

ORCID-Profile: Gregory Oxenkrug, Stefano Comai

Zitieren

APA

Oxenkrug, G., & Comai, S. (2026). Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition. International Journal of Tryptophan Research, 19. https://doi.org/10.1177/11786469261472317

Vancouver

Oxenkrug G, Comai S. Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition. International Journal of Tryptophan Research. 2026;19. doi:10.1177/11786469261472317

BibTeX
@article{Oxenkrug2026,
  author = {Oxenkrug, Gregory and Comai, Stefano},
  title = {Up-Regulation of Anthranilic Acid Formation and Pro-Cognitive Effect of Indoleamine 2,3-Dioxygenase Inhibition},
  journal = {International Journal of Tryptophan Research},
  year = {2026},
  volume = {19},
  doi = {10.1177/11786469261472317}
}
Kostenlos starten →